Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension
about
Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic HypertensionAngiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive ratsAngiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive ratsA mechanism-based approach to prevention of and therapy for fibromyalgia.Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity.Mechanisms and therapeutic potential of microRNAs in hypertension.Neuroimmune communication in hypertension and obesity: a new therapeutic angle?Pharmacological studies of tentacle extract from the jellyfish Cyanea capillata in isolated rat aortaEffect of simvastatin in the autonomic system is dependent on the increased gain/sensitivity of the baroreceptors.Essential hypertension: an approach to its etiology and neurogenic pathophysiology.The sympathetic nervous system and blood pressure in humans: implications for hypertension.Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.Adipose afferent reflex: sympathetic activation and obesity hypertension.Blood pressure regulation XI: overview and future research directions.Autonomic nervous system dysregulation in pediatric hypertension.Cardiac sympathetic afferent reflex and its implications for sympathetic activation in chronic heart failure and hypertension.c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure.Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats.SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats.Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats.Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats.Endogenous hydrogen peroxide in paraventricular nucleus mediates sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats.Angiotensin AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats.Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.Exercise training causes sympathoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive rats.Sympathetic activation by chemical stimulation of white adipose tissues in rats.Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.Sympathovagal balance from heart rate variability: time for a second round?
P2860
Q22306336-A98E0906-B65F-4BC1-937D-9B22590F952EQ34472153-EF06EBD0-D56B-4446-94A5-F64E0E990619Q34534106-C5B228D4-0F56-4863-A3D8-16A2F88D00D1Q35431543-EB5ABD83-AE00-4702-ADFC-F1E9C77411CDQ36042674-D2DD4823-2876-47BD-80B8-F68789BE3492Q36173562-2C2800D8-3149-4E71-A983-9BB44804B2ABQ36824063-383348A9-ED5B-4D70-A77E-3882B325C0ACQ37250731-A5F52177-D9E1-49D8-A647-A11EB55CB4D8Q37328067-ABA56261-DD7B-4CAA-908E-EDE4B79D5F48Q37412877-B7092754-1872-4056-936B-E1311ADA0FD2Q37898511-24B9D8EC-B848-4534-9081-B70DF6648F14Q38110197-B769A5BE-3F48-4591-94BA-02D372FD2AABQ38151943-3A6E5DAD-55DA-4B50-BE97-9586E13A9E62Q38181897-58987D21-33E5-4A1E-9092-90B498B01575Q38196354-7B2B17FC-1E13-4859-B0E6-7797DEA45757Q38322686-21D64513-D78C-43A0-A478-BE77112A5BC6Q42749550-D2B87260-A205-48E1-AF85-5E5F4D43502CQ44523641-DBE820EC-06C9-417A-8F7C-21C242D3A1D7Q45873654-E637E186-0CFC-448E-B26F-178348890549Q46514659-2F9886CC-E656-4CDE-B24C-0DFA45F99D83Q47396920-75126F68-756C-4482-BE8C-73DCE52C2CE9Q47865079-0BDC3619-DAA0-4815-B020-7678882FFBCAQ48233757-AEE21D68-E99E-4FC0-AB0D-0EA8DC8C8175Q48310428-CE1B00D7-7994-4114-9FE8-F61F8E79E720Q48448938-73731A98-3AEF-48D6-AC12-C14B1E0ED84FQ48472551-D0F0B38E-EFBA-4935-8DFF-C50CF44A4E48Q48518493-C408C5A8-52C4-43F6-81E4-2D753B246835Q48725178-8FCC02AB-C9C1-41CB-98B9-0E1DAB124653Q48983840-552D5C11-A628-4CF8-A94C-85F16F5CFDA0Q49418865-ECF97EFB-8DFA-486B-9657-B11CC6F41A73Q58859920-867C1DD1-D4A1-4BAF-BECA-C2492145EF76
P2860
Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic strategies for tar ...... tivation in human hypertension
@ast
Therapeutic strategies for tar ...... tivation in human hypertension
@en
type
label
Therapeutic strategies for tar ...... tivation in human hypertension
@ast
Therapeutic strategies for tar ...... tivation in human hypertension
@en
prefLabel
Therapeutic strategies for tar ...... tivation in human hypertension
@ast
Therapeutic strategies for tar ...... tivation in human hypertension
@en
P2860
P1476
Therapeutic strategies for tar ...... tivation in human hypertension
@en
P2093
Paul J Fadel
P2860
P304
P356
10.1113/EXPPHYSIOL.2009.047332
P50
P577
2010-03-19T00:00:00Z